Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001232 · ClinicalTrials.gov registry record

The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
140
Enrollment target

NCT00001232 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001232 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
140 participants
Enrollment target

Study Summary

The normal menstrual cycle is produced by a series of hormonal signals that starts with the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. The hypothalamus is located in the brain and is often referred to as the master gland. GnRH then acts on the pituitary gland and causes it to release two hormones, follicle stimulating hormone (FSH) and lutenizng hormone (LH). LH and FSH act on the ovary and cause it to release the hormones directly involved in menstruation, estrogen and progesterone. The purpose of this research study is to evaluate the hypothalamic-pituitary-gonadal axis activity as measured by pituitary hormones, FSH and LH in response to intravenous doses of gonadotropin releasing hormone (GnRH) in menstrual cycle-related hormones.

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 1988-07
Est. Completion 2000-06

What the Registry Record Tells You About NCT00001232

The ClinicalTrials.gov registry entry for NCT00001232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001232 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001232 about?

NCT00001232 is a clinical study titled "The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders". The normal menstrual cycle is produced by a series of hormonal signals that starts with the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. The hypothalamus is located in the brain and is often referred to as the master gland. GnRH then acts on the pituitary gland and causes ...

What is the current status of trial NCT00001232?

This trial is currently completed. The enrollment target is 140 participants. The study started on 1988-07. Estimated completion is 2000-06.

Who is sponsoring clinical trial NCT00001232?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.